Clinical Trial Update: Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing iso-osmolar versus low-osmolar contrast agents for Optical Coherence Tomography in patients with coronary artery disease and cont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Minneapolis Heart Institute Foundation | Conditions: Coronary Artery Disease, Contrast Media Reaction | Phase 4 | Status: UNKNOWN